ClinicalTrials.gg
Sign In

Stomach Neoplasms clinical trials

The registry lists 3,399 studies for Stomach Neoplasms across more than 10 countries. 992 are recruiting or about to start. 2,331 of them are mainly about Stomach Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Gastro-enteropancreatic neuroendocrine tumor too: 3,467 studies, 1,011 open.

ClinicalTrials.gov finds 4,382 studies for Stomach Neoplasms. How that becomes 3,397 here

This page counts the studies the registry files under Stomach Neoplasms, and those it files under no condition that list Stomach Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 4,382Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −59Filed under a narrower condition, counted on its own pageGastro-enteropancreatic neuroendocrine tumor 57
  3. −46List Stomach Neoplasms as a condition, but the registry did not file them under itMost often written as “Clinical Stage IV Gastric Cancer AJCC v8” (11), “Clinical Stage III Gastric Cancer AJCC v8” (10), and “Advanced Gastric Cancer” (5). The registry filed them under other conditions only, most often Neoplasm Metastasis (8) and Colorectal Neoplasms (7).
  4. −880Match it another way217 name it in the title, 12 in a keyword, and 651 by a synonym or other text the search reads.
  5. 3,397The count on this page213 of them list Stomach Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Stomach Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,219
Recruiting
702
Status unknown
680
Not yet recruiting
258
Terminated
219
Active, not recruiting
207

Phase

Phase 2
1,187
Phase 1
693
Phase 3
323
Phase 4
71
Early Phase 1
41

Where

China
1,180
United States
804
Korea, Republic of
521
Japan
181
Spain
173
Germany
161

Who runs them

Yonsei University (80) · National Cancer Institute (NCI) (64) · Fudan University (58) · Fujian Medical University (56) · Peking University (43) · Samsung Medical Center (40) · National Cancer Center, Korea (38) · Memorial Sloan Kettering Cancer Center (37)

What is being tested here

Drugs under test in Stomach Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sintilimab27441
Oxaliplatin1823123
Tislelizumab16423
Paclitaxel13979
Apatinib131347
Disitamab vedotin12518
HMPL-01311115
Docetaxel91297
Capecitabine91890
Tegafur91661

Drug classes tested here Immune checkpoint inhibitors 121 open · Tyrosine kinase inhibitors (TKIs) 48 open · Antimetabolites 27 open · Antimitotic agents 23 open · Antibody-drug conjugates (ADCs) 23 open

Coming up

91phase 3 studies under way
292studies finish main data collection within a year16 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 702 Stomach Neoplasms studies recruiting now, 375 (53%) set no upper age limit and 194 (28%) stop at 75 or younger. 28 (4%) take children under 18. 2 (<1%) are for women only and 0 (0%) for men only; 68 (10%) take healthy volunteers.

Recruiting studies that take each age, of 702
AgeWomenMen
1025 (4%)25 (4%)
18609 (87%)607 (86%)
30677 (96%)675 (96%)
40691 (98%)689 (98%)
50695 (99%)693 (99%)
65696 (99%)694 (99%)
75656 (93%)654 (93%)
85429 (61%)427 (61%)

Across all 3,399 studies, recruiting or not: 27% stop at 75 or younger and 2% at 65; 6% take children; <1% are for women only and <1% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Stomach Neoplasms studies take

Of 358 phase 2 interventional studies under Stomach Neoplasms, half reached primary completion within 50 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 151 mo33–66 · 242 studies50 mo34–65 · 167 studies53 mo31–… · 75 studies
Phase 1/260 mo41–109 · 156 studies60 mo41–109 · 89 studies60 mo36–133 · 67 studies
Phase 250 mo31–75 · 358 studies38 mo25–68 · 65 studies57 mo32–76 · 293 studies
Phase 2/349 mo28–52 · 26 studies——
Phase 352 mo39–96 · 118 studies45 mo32–55 · 45 studies79 mo46–144 · 73 studies
Phase 412 mo11–17 · 27 studies——
Interventional, no phase36 mo17–63 · 367 studies—36 mo17–66 · 356 studies
Observational54 mo29–119 · 364 studies—57 mo29–171 · 322 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting8

Show 3 more

Results posted1

Stopped3

Newly registered31

Show 26 more

Studies

Recruiting first, then most recently updated. Showing 50 of 3,399. Browse all 3,399 → or search them.